Attrition Prevalence 18 Percent for General Surgery Residents

Share this content:
Attrition Prevalence 18 Percent for General Surgery Residents
Attrition Prevalence 18 Percent for General Surgery Residents

THURSDAY, Dec. 15, 2016 (HealthDay News) -- The estimated prevalence of attrition is 18 percent among general surgery residents, according to a review published online Dec. 14 in JAMA Surgery.

Zeyad Khoushhal, M.B.B.S., M.P.H., from St. Michael's Hospital in Toronto, and colleagues conducted a systematic literature review to summarize the estimate of attrition prevalence among general surgery residents. Twenty-two studies were included that reported on 19,821 residents from general surgery programs.

The researchers found that among general surgery residents, the pooled estimate for the overall attrition prevalence was 18 percent, with significant variation between studies (P < 0.001). Attrition was significantly higher among females than males (25 versus 15 percent; P = 0.008); 48 percent of residents left after their first postgraduate year. Twenty percent of departing residents relocated to another general surgery program; others switched to other specialties, including anesthesia (13 percent). Uncontrollable lifestyle and transferring to another specialty were the most common reported causes of attrition.

"General surgery programs have relatively high attrition, with female residents more likely to leave their training programs than male residents," the authors write. "Residents most often relocate or switch to another specialty after the first postgraduate year owing to lifestyle-related issues."

Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »